-
Cancer Control in the Community
Successful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
-
Advocacy in Action
Fearless FriendsLori Marx-Rubiner and AnneMarie Ciccarella met on social media and grew close through their cancer research advocacy.
by Sue Rochman
-
Scholarships for Survivors
Cancer survivor creates scholarship fund for young adult cancer survivors.
by Lindsey Konkel
-
Forward Look
Scientists Take a StandThousands of attendees who gathered at the Opening Ceremony of the American Association for Cancer Research (AACR) Annual Meeting 2017 sent a message on April 2 that cuts proposed by the Trump administration to the National Institutes of Health (NIH) budget would be devastating to cancer research, stall progress and ultimately harm cancer patients. The Annual […]
by Sue Rochman
-
A New Look for Clinical Trials
More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.
by Sue Rochman
-
Forward Look
More Options for Adolescents in Clinical TrialsNew recommendations support inclusion of teens in adult studies.
by Susan Kreimer
-
Survivor Profile
The Gift of MusicA self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire.
by Jenny Song
-
Q&A
Trial GuideResearcher Tom Marsilje is helping fellow colorectal cancer patients sort through clinical trials.
by Kate Yandell
-
Get Involved
A Home Away From HomeAnn W. Calahan started Joe's House to help cancer patients and others find places to stay when they're being treated away from home.
by Cameron Walker
-
AACR Scientist↔Survivor Program: The Patient Perspective
In a sea of p-values and distribution curves, patient advocates and survivors at a scientific gathering remind researchers who is behind the numbers.
by Marci A. Landsmann
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona